Skip to main content
. 2022 Sep 27;2022(9):CD010287. doi: 10.1002/14651858.CD010287.pub4

Saha 2020.

Methods Randomised controlled trial
Participants Total 108 anovulatory PCO women in the age group 20 to 36 years who had previous R3 failed treatment cycles with CC
Interventions Group A: letrozole plus 3 doses of gonadotropin
Group B: continuous gonadotropin 
54 patients in each group
Outcomes Both groups were evaluated in respect of terminal endocrinological profile, number of follicles, ovulation rate, pregnancy rate and outcome, adverse effects and cost‐effectivity.
Notes Only conference abstract found, no full article available; no further trial or author information